GH Technolgies
Based on its clinical expertise George Health Technologies is transforming the delivery of essential care for chronic diseases to make proven personalised healthcare plans widely accessible to patients, their physicians and carers. Our clinical intelligence platform – SMARThealth – enables early detection of multiple chronic disease risks, creates a personalised, guideline-based care plan and manages follow up to improve treatment adherence.
8 million deaths
in low-and middle-income countries are due to conditions that should be treatable by the health system.
Over 50%
of patients are not on guideline-based care in established markets and it’s estimated that 80% are not in emerging countries.
5.4x higher
costs for treating multi-morbidity patients than patients with no diseases and 2.7x more than single disease patients.
Billions of dollars are spent advancing evidenced-based medical knowledge and establishing treatment protocols and guidelines. However, data shows that there is a significant gap between the care that patients should be getting and the care they actually receive. SMARThealth was designed and tested to close this critical gap. Its intelligent clinical decision support and patient assistance tools are proven to deliver better care and improve health outcomes around the world.
What we do
George Health Technologies uses clinically proven digital health algorithms to cut through complexity and transform the management of multiple diseases in a single patient. SMARThealth uses these algorithms to screen for high-risk patients and provide personalised, guideline-based programs that manage patients with multi-morbidities. Harnessing the latest clinical knowledge at the point-of-care saves primary care and specialist providers valuable time and increases the quality of care and outcomes for those most at risk. Our patient engagement tools are a catalyst to motivate patients to adhere to the management of their conditions.
George Health Technologies partners with organisations globally to improve patient outcomes for the treatment of non-communicable diseases.
We work with our partners including care providers, insurers, employers and healthcare companies, to deliver high-quality care at a much lower cost than is currently possible.
Result
Led by the clinical experts at The George Institute, SMARThealth has already been tested in four countries across Asia. Its user interfaces have been co-designed with patients, providers and payers. Our training and integration programs have achieved dramatic improvements using existing health workforces. This cost-effective approach brings considerable benefits to the health system.
screened 350k patients
and counting
transformed guideline-based care
with >100% improvements.
very cost-effective interventions
using WHO guidelines.
Profit with purpose – delivering sustainable impact and attractive returns
Better treatments, Better care,
Healthier societies
New frontiers
George
Clinical
Science, service, solutions. A leading contract research organisation in Asia-Pacific with global capabilities.
Novel Treatments
George
Medicines
Innovative, affordable treatments for the leading causes of death globally.
Disruptive technologies
